Clinical Trial Location: Hungary

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib (STOP-LTR)

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa